Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Citroma, Citroma Lemon,nCitrate of Magnesia
Synonyms :
magnesium citrate
Class :
Laxative
Brand Name :
Citroma, Citroma Lemon,nCitrate of Magnesia
Synonyms :
magnesium citrate
Class :
Laxative
Dosage Forms & StrengthsÂ
TabletÂ
100mg Â
LiquidÂ
290mg/5mlÂ
Indicated as laxative:
195–300 mL PO, either as a single dose or split doses, with a full glass of water each day
Alternatively,2 to 4 tablets orally in the night-time
Indicated for nutritional supplement:
>30 years:
The current recommendations for daily magnesium intake are:
Adult men (31 years and older): 420 mg/day
Adult women (31 years and older): 320 mg/day
Pregnant women: 350-400 mg/day
Breastfeeding women: 310-360 mg/day
<30 years:
The NIH recommends the following daily magnesium intake for individuals aged 19-30:
Adult men (19-30 years): 400 mg/day
Adult women (19-30 years): 310 mg/day
Pregnant women: 350-400 mg/day
Breastfeeding women: 310-360 mg/day
One tablet two times a day
Dosage Forms & StrengthsÂ
TabletÂ
100mg Â
LiquidÂ
290mg/5mlÂ
<2 years: Safety and Efficacy not established
2 to 6 years: 60 to 90ml orally in a single or divided dose. Do not exceed 90ml for 24 hours
6 to 12 years: 90 to 210ml orally in a single dose or divided doses with a full glass of water
>12 years: 195 to 300ml orally in a single dose or in divided doses with a full glass of water
Administer 2 to 4 tablets orally before bedtime
Refer adult dosingÂ
bismuth subcitrate, metronidazole and tetracycline
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
may enhance the serum concentration of magnesium salts
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
tetraferric tricitrate decahydrate
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
bismuth subcitrate, metronidazole and tetracycline
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may reduce the levels of serum concentration of multivitamins
may reduce the level of serum concentration of quinolones
may reduce the level of serum concentration of quinolones
may diminish the absorption when combined with tetracyclines
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the absorption of phosphate binders
magnesium Salts may decrease the serum concentration of Dolutegravir
magnesium Salts may decrease the serum concentration of quinolones
magnesium Salts may decrease the serum concentration of quinolones
may diminish the serum concentration of quinolones
may have an increased hypermagnesemic effect when combined with magnesium salts
may have a decreased absorption when combined with alpha-lipoic acid
may increase the serum concentration when combined with magnesium salts
may have a decreased serum concentration when combined with dolutegravir
may have a decreased serum concentration when combined with quinolones
may have a decreased serum concentration when combined with quinolones
bismuth subcitrate, metronidazole and tetracycline
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
acalabrutinib: they may diminish the serum concentration of magnesium salts
alfacalcidol: they may enhance the serum concentration of magnesium salts
atazanavir: they may diminish the absorption of magnesium salts
cefuroxime: they may diminish the serum concentration of magnesium salts
chloroquine: they may diminish the serum concentration of magnesium salts
dabigatran: they may diminish the serum concentration of magnesium salts
delavirdine: they may diminish the serum concentration of magnesium salts
eltrombopag: they may increase the hypermagnesemic effect of magnesium salts
fosinopril: they may increase the CNS depressant effect of magnesium salts
infigratinib: they may diminish serum concentrations of magnesium salts
may diminish the serum concentration of magnesium salts
bismuth subcitrate, metronidazole and tetracycline
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of magnesium salts
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may diminish the serum concentration of magnesium salts
may diminish the serum concentration of polyvalent cation-containing products
may diminish the serum concentration of polyvalent cation-containing products
may diminish the serum concentration of polyvalent cation-containing products
may diminish the serum concentration of polyvalent cation-containing products
may diminish the serum concentration of polyvalent cation-containing products
it may inhibit the GI absorption of demeclocycline (provide 2 hours difference between both drugs)
it may inhibit the GI absorption of doxycycline (provide 2 hours difference between both drugs)
may diminish the serum concentration when combined with raltegravir
may have an increased CNS depressant effect when combined with gabapentin
may have a decreased serum concentration when combined with levothyroxine
may have a decreased serum concentration when combined with fluoride/multivitamins (with ADE)
may decrease the serum concentration of Polyvalent Cation Containing Products
levonorgestrel: they may diminish the serum concentration of magnesium salts
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the effect of neuromuscular-blocking agents
may reduce the rate of absorption of tetracyclines
may reduce the rate of absorption of tetracyclines
may reduce the rate of absorption of tetracyclines
It may enhance the levels when combined with sodium polystyrene sulfonate by diminishing renal clearance
It may enhance the effects when combined with vitamin D
it may enhance the risk of side effects when combined with misoprostol
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the effects of the drug by GI absorption inhibition
Actions and Spectrum:Â
Frequency not definedÂ
DiarrheaÂ
HypermagnesemiaÂ
Nausea/vomitingÂ
Abdominal crampingÂ
Electrolyte imbalanceÂ
Gas formationÂ
Contraindications/caution:Â
Contraindications:Â
The contraindications of magnesium citrate include:Â
Caution:Â
Pregnancy consideration: AÂ
Lactation: Excretion of the drug in human breast milk is knownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Pharmacology:Â
Pharmacodynamics:Â
Pharmacokinetics:Â
AbsorptionÂ
magnesium citrate is administered orally and is rapidly absorbed from the gastrointestinal tract. Food enhances absorption, which slows gastric emptying and increases the time that magnesium citrate is in contact with the intestinal wall. The absorption of magnesium citrate can be affected by medications, food, and other factors that affect gastrointestinal motility. Â
DistributionÂ
Once absorbed, magnesium citrate is distributed throughout the body, with the highest concentrations in the bones, muscles, and soft tissues. magnesium citrate crosses the blood-brain barrier and the placenta and is also excreted into breast milk. Â
MetabolismÂ
magnesium citrate is not metabolized in the body and is excreted unchanged. Â
Elimination and ExcretionÂ
magnesium citrate is primarily excreted by the kidneys, with about 50% of the dose excreted in the urine within 24 hours of administration. In individuals with impaired kidney function, the medication may not be adequately cleared from the body, leading to an accumulation of magnesium and potential adverse effects.Â
Administration:Â
magnesium citrate is usually taken orally as a liquid solution. Here are some general guidelines for the administration of magnesium citrate:Â
Patient information leafletÂ
Generic Name: magnesium citrateÂ
Why do we use magnesium citrate?Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
